Sales slipped 6% and net profits 11% in Q2 for DSM’s human and animal nutrition arm as adverse currency movements, a slow US vitamins and omega-3 food supplements market and the Asian botulism infant formula scare affected earnings.
Royal DSM paid tribute to its nutrition division which held steady as its sales and profits dipped for the second quarter and first half of the financial year, as recessed global economies took their toll on bottom lines.